AJP - Renal Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 287: F215-F223, 2004; doi:10.1152/ajprenal.00376.2003
0363-6127/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stam, F.
Right arrow Articles by de Meer, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stam, F.
Right arrow Articles by de Meer, K.

Homocysteine clearance and methylation flux rates in health and end-stage renal disease: association with S-adenosylhomocysteine

Frank Stam,1,2 Coen van Guldener,1,2,3 Piet M. ter Wee,2,4 Willem Kulik,5 Desirée E. C. Smith,5 Cornelis Jakobs,5 Coen D. A. Stehouwer,1,2 and Kees de Meer2,5

1Department of Internal Medicine, 2Institute for Cardiovascular Research, 4Department of Nephrology, and 5Department of Clinical Chemistry, Vrije Universiteit Medical Center, 1081 HV Amsterdam; and 3Department of Internal Medicine, Amphia Hospital, 4800 RL Breda, The Netherlands

Submitted 28 October 2003 ; accepted in final form 25 March 2004

Hyperhomocysteinemia is a risk factor for cardiovascular disease and occurs frequently in end-stage renal disease (ESRD), but its pathogenesis is poorly understood. We aimed to evaluate one-carbon flux rates of methionine and homocysteine (Hcy) in ESRD patients and healthy controls. Transmethylation (TM), remethylation (RM), and transsulfuration (TS), as well as Hcy clearance by TS (i.e., TS/plasma total Hcy concentration) and by RM (i.e., RM/plasma total Hcy concentration) were evaluated in relation to body composition, vitamins, and S-adenosylhomocysteine (AdoHcy) and S-adenosylmethionine (AdoMet) levels. After a fixed protein diet for 3 days, primed-continuous infusion of [2H3-methyl-1-13C]methionine was performed in the postabsorptive state in 12 hemodialysis patients and 16 healthy volunteers. Hcy clearance by TS (–80%, P < 0.001) and by RM (–77%, P < 0.001) in ESRD patients was decreased compared with healthy controls. The absolute flux rates of TM (–27%, P < 0.01) and RM (–28%, P = 0.02) were lower in the ESRD patients. After adjustment for age, TS was not significantly reduced. Whole blood AdoHcy was significantly elevated in ESRD and was a significant determinant of TM (standardized {beta} = –1.24, P = 0.01) and RM (standardized {beta} = –1.43, P = 0.03). In conclusion, patients with ESRD have impaired Hcy clearance by TS and RM. Elevated whole blood AdoHcy levels are associated with impaired RM and TM flux rates in these patients, and AdoHcy may be a key regulatory compound in one-carbon flux.

stable isotopes; S-adenosylmethionine; transsulfuration; remethylation; transmethylation



Address for reprint requests and other correspondence: F. Stam, Dept. of Internal Medicine, VU Univ. Medical Ctr., De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands (E-mail: f.stam{at}vumc.nl).




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
P. Stenvinkel and T. J. Ekstrom
Epigenetics--a helpful tool to better understand processes in clinical nephrology?
Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1493 - 1496.
[Full Text] [PDF]


Home page
J. Nutr.Home page
K. T. Williams and K. L. Schalinske
New Insights into the Regulation of Methyl Group and Homocysteine Metabolism
J. Nutr., February 1, 2007; 137(2): 311 - 314.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
M. Herrmann, O. Taban-Shomal, U. Hubner, M. Bohm, and W. Herrmann
A review of homocysteine and heart failure
Eur J Heart Fail, October 1, 2006; 8(6): 571 - 576.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. van Guldener
Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering?
Nephrol. Dial. Transplant., May 1, 2006; 21(5): 1161 - 1166.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. Fux, D. Kloor, M. Hermes, T. Rock, B. Proksch, A. Grenz, U. Delabar, R. Bucheler, S. Igel, K. Morike, et al.
Effect of acute hyperhomocysteinemia on methylation potential of erythrocytes and on DNA methylation of lymphocytes in healthy male volunteers
Am J Physiol Renal Physiol, October 1, 2005; 289(4): F786 - F792.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.